Knocking down Set1 in SLE CD4+ T cells alleviated the CREMα promoter H3K4me3 enrichment, suppressed the expressions of CREMα and IL-17A, and elevated the levels of IL-2, CREMα promoter DNA methylation, and DNMT3a. This evidence concerns the gene IL2 and systemic lupus erythematosus.